Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2012 3
2013 2
2014 4
2015 6
2016 7
2017 5
2018 7
2019 7
2020 8
2021 8
2022 6
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Microglial Activation and Progression of Nigrostriatal Dysfunction in Isolated REM Sleep Behavior Disorder.
Staer K, Iranzo A, Stokholm MG, Hvingelby VS, Danielsen EH, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Santamaria J, Møller A, Gaig C, Brooks DJ, Borghammer P, Tolosa E, Pavese N. Staer K, et al. Among authors: vilas d. Mov Disord. 2024 Mar 13. doi: 10.1002/mds.29767. Online ahead of print. Mov Disord. 2024. PMID: 38477376
Agreement of cerebrospinal fluid biomarkers and amyloid-PET in a multicenter study.
Guillén N, Contador J, Buongiorno M, Álvarez I, Culell N, Alcolea D, Lleó A, Fortea J, Piñol-Ripoll G, Carnes-Vendrell A, Lourdes Ispierto M, Vilas D, Puig-Pijoan A, Fernández-Lebrero A, Balasa M, Sánchez-Valle R, Lladó A. Guillén N, et al. Among authors: vilas d. Eur Arch Psychiatry Clin Neurosci. 2023 Oct 28. doi: 10.1007/s00406-023-01701-y. Online ahead of print. Eur Arch Psychiatry Clin Neurosci. 2023. PMID: 37898567
Progression of brain cholinergic dysfunction in patients with isolated rapid eye movement sleep behavior disorder.
Staer K, Iranzo A, Terkelsen MH, Stokholm MG, Danielsen EH, Østergaard K, Serradell M, Otto M, Svendsen KB, Garrido A, Vilas D, Santamaria J, Møller A, Gaig C, Brooks DJ, Borghammer P, Tolosa E, Pavese N. Staer K, et al. Among authors: vilas d. Eur J Neurol. 2024 Jan;31(1):e16101. doi: 10.1111/ene.16101. Epub 2023 Oct 17. Eur J Neurol. 2024. PMID: 37847229
Peripheral α-synuclein isoforms are potential biomarkers for diagnosis and prognosis of isolated REM sleep behavior disorder.
Arnaldo L, Urbizu A, Serradell M, Gaig C, Anillo A, Gea M, Vilas D, Ispierto L, Muñoz-Lopetegi A, Mayà G, Pastor P, Álvarez R, Santamaria J, Iranzo A, Beyer K. Arnaldo L, et al. Among authors: vilas d. Parkinsonism Relat Disord. 2023 Oct;115:105832. doi: 10.1016/j.parkreldis.2023.105832. Epub 2023 Sep 3. Parkinsonism Relat Disord. 2023. PMID: 37678102
Brainstem neuromelanin and iron MRI reveals a precise signature for idiopathic and LRRK2 Parkinson's disease.
Martínez M, Ariz M, Alvarez I, Castellanos G, Aguilar M, Hernández-Vara J, Caballol N, Garrido A, Bayés À, Vilas D, Marti MJ; Catalonian Neuroimaging Parkinson’s disease Consortium; Pastor P, de Solórzano CO, Pastor MA. Martínez M, et al. Among authors: vilas d. NPJ Parkinsons Dis. 2023 Apr 15;9(1):62. doi: 10.1038/s41531-023-00503-2. NPJ Parkinsons Dis. 2023. PMID: 37061532 Free PMC article.
Parsonage-Turner Syndrome After COVID-19 Vaccination in a Child.
Cassart EM, Vilas DR, Abe R, Cavanilles-Walker JM. Cassart EM, et al. Among authors: vilas dr. J Am Acad Orthop Surg Glob Res Rev. 2023 Mar 9;7(3):e22.00156. doi: 10.5435/JAAOSGlobal-D-22-00156. eCollection 2023 Mar 1. J Am Acad Orthop Surg Glob Res Rev. 2023. PMID: 36893168 Free PMC article.
Trial of Deferiprone in Parkinson's Disease.
Devos D, Labreuche J, Rascol O, Corvol JC, Duhamel A, Guyon Delannoy P, Poewe W, Compta Y, Pavese N, Růžička E, Dušek P, Post B, Bloem BR, Berg D, Maetzler W, Otto M, Habert MO, Lehericy S, Ferreira J, Dodel R, Tranchant C, Eusebio A, Thobois S, Marques AR, Meissner WG, Ory-Magne F, Walter U, de Bie RMA, Gago M, Vilas D, Kulisevsky J, Januario C, Coelho MVS, Behnke S, Worth P, Seppi K, Ouk T, Potey C, Leclercq C, Viard R, Kuchcinski G, Lopes R, Pruvo JP, Pigny P, Garçon G, Simonin O, Carpentier J, Rolland AS, Nyholm D, Scherfler C, Mangin JF, Chupin M, Bordet R, Dexter DT, Fradette C, Spino M, Tricta F, Ayton S, Bush AI, Devedjian JC, Duce JA, Cabantchik I, Defebvre L, Deplanque D, Moreau C; FAIRPARK-II Study Group. Devos D, et al. Among authors: vilas d. N Engl J Med. 2022 Dec 1;387(22):2045-2055. doi: 10.1056/NEJMoa2209254. N Engl J Med. 2022. PMID: 36449420 Clinical Trial.
Salivary ATP13A2 is a potential marker of therapy-induced motor complications and is expressed by inclusions in submandibulary glands in Parkinson ´s disease.
Fernández-Espejo E, Gavito AL, Suárez J, Tolosa E, Vilas D, Aldecoa I, Berenguer J, Córdoba-Fernández A, Damas-Hermoso F, Rodríguez de Fonseca F. Fernández-Espejo E, et al. Among authors: vilas d. Clin Park Relat Disord. 2022 Aug 28;7:100163. doi: 10.1016/j.prdoa.2022.100163. eCollection 2022. Clin Park Relat Disord. 2022. PMID: 36081833 Free PMC article.
67 results